Curocell Inc.

₩21,050As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:372320Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (8.18%)
Div yield —
ROE (101.11%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.66
PE TTM —
TSR TTM (43.94%)
Mkt cap ₩320.5B
ROIC (20.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩21,600
2.61%
(69.02%)
Hold 7|7|3|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
216.04
208.49
224.77
225.21
26.17%
19.06%
22.57%
16.70%
Revenue₩B
21.91
22.65
23.70
23.92
10.06%
16.21%
15.92%
11.31%
Peers (US$236.3M)
Cap (US$)
PE
217.0M
—
222.5M
—
Capital
TTM
5Y
10Y
Leveragex
2.468
(0.200)
(0.206)
EBIT/Intx
0.791
0.254
0.320
Own earn%
115.21
29.15
30.01
Sh yield%
51.48
38.45
35.91
Owners
Insiders/Inst%
12.98
73.30
Short interest%
4.05
SBC / revenue%
4.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
12–16
$1 testx
—
Incr. ROIC%
0